We are live on ! Find out more
ERNA icon

Ernexa Therapeutics

7 hedge funds and large institutions have $7.92M invested in Ernexa Therapeutics in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5,442% more capital inflows, than outflows

Capital inflows: $2.77M | Capital outflows: $50K

0% more funds holding

Funds holding: 7 → 7 (0)

21.4% less ownership

Funds ownership: 21.4% → 0% (-21%)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$44K
2
CL
CSS LLC
Illinois
-$6K

ERNA Hedge Fund Activity: Q4 2014 in Review

7 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Ernexa Therapeutics (ERNA) for Q4 2014, worth a combined $7.92M — up 30% from $6.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ERNA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest seller was Dimensional Fund Advisors, cutting an estimated $44K.

  • 7 institutional investors held Ernexa Therapeutics (ERNA) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $7.92M of Ernexa Therapeutics stock for Q4 2014, up 30% quarter-over-quarter.
  • 1 fund opened new Ernexa Therapeutics positions in Q4 2014 and 0 closed out, a net change of +1 holder.
  • The largest Ernexa Therapeutics seller in Q4 2014 was Dimensional Fund Advisors, an estimated $44K sold.

Based on aggregated 13F filings for Q4 2014.